Effective Jan. 1, 2027, for some UnitedHealthcare commercial and Individual and Family Exchange plans, we’ll require prior authorization for some new procedure codes that the American Medical Association (AMA) has issued for genetic and molecular testing.
These codes are consistent with genetic and molecular tests that currently require prior authorization. Overall, we’re reducing the number of CPT® codes requiring prior authorization, but we may add prior authorization as new information, such as new codes from AMA, becomes available.
This affects the following plans in all states:
In addition to the current in-scope procedure codes, the following codes will be added to the existing prior authorization/advance notification requirements:
For training, view our Prior Authorization and Notification Interactive Guide
If we don’t receive a prior authorization request before the date of service, we’ll deny the claim and you won’t be able to balance bill members.
If you have questions, please visit our Prior Authorization and Notification resource.
CPT® is a registered trademark of the American Medical Association.
PCA-1-26-01726-Clinical-NN_09152026